Net Cash Provided by (Used in) Financing Activities of Lexaria Bioscience Corp. from 31 Oct 2010 to 30 Nov 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Lexaria Bioscience Corp. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Oct 2010 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Nov 2025 was $3,474,051, a 20% decline year-over-year.
  • Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $6,046,163, a 41% decline from 2024.
  • Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $10,315,207, a 549% increase from 2023.
  • Lexaria Bioscience Corp. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1,589,731.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Lexaria Bioscience Corp. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $3,474,051 -$871,342 -20% 01 Sep 2025 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q4 2024 $4,345,393 +$2,526,023 +139% 01 Sep 2024 30 Nov 2024 10-Q 13 Jan 2026 2026 Q1
Q4 2023 $1,819,370 +$1,819,370 01 Sep 2023 30 Nov 2023 10-Q 10 Jan 2025 2025 Q1
Q4 2022 $0 +$10,987 01 Sep 2022 30 Nov 2022 10-Q 12 Jan 2024 2023 Q1
Q4 2021 $10,987 -$2,220 -25% 01 Sep 2021 30 Nov 2021 10-Q/A 18 Jan 2023 2023 Q1
Q4 2020 $8,767 -$715,471 -101% 01 Sep 2020 30 Nov 2020 10-Q 14 Jan 2022 2022 Q1
Q4 2019 $706,704 -$942,486 -57% 01 Sep 2019 30 Nov 2019 10-Q 14 Jan 2021 2021 Q1
Q4 2018 $1,649,190 +$1,366,788 +484% 01 Sep 2018 30 Nov 2018 10-Q 09 Jan 2020 2020 Q1
Q4 2017 $282,402 +$136,894 +94% 01 Sep 2017 30 Nov 2017 10-Q 11 Jan 2019 2019 Q1
Q4 2016 $145,508 +$109,508 +304% 01 Sep 2016 30 Nov 2016 10-Q 12 Jan 2018 2018 Q1
Q4 2015 $36,000 +$134,743 01 Sep 2015 30 Nov 2015 10-Q 13 Jan 2017 2017 Q1
Q4 2014 $98,743 -$178,743 -223% 01 Sep 2014 30 Nov 2014 10-Q 08 Jan 2016 2016 Q1
Q4 2013 $80,000 +$246,925 01 Nov 2013 31 Jan 2014 10-Q 12 Mar 2014 2014 Q1
Q4 2012 $166,925 -$366,925 -183% 01 Nov 2012 31 Jan 2013 10-Q 12 Mar 2014 2014 Q1
Q4 2011 $200,000 -$329,600 -62% 01 Nov 2011 31 Jan 2012 10-Q 13 Mar 2013 2013 Q1
Q4 2010 $529,600 01 Nov 2010 31 Jan 2011 10-Q 13 Mar 2012 2012 Q1

Lexaria Bioscience Corp. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $6,046,163 -$4,269,044 -41% 01 Sep 2024 31 Aug 2025 10-K 28 Nov 2025 2025 FY
2024 $10,315,207 +$8,725,476 +549% 01 Sep 2023 31 Aug 2024 10-K 28 Nov 2025 2025 FY
2023 $1,589,731 +$1,634,331 01 Sep 2022 31 Aug 2023 10-K 20 Nov 2023 2023 FY
2022 $44,600 -$13,464,446 -100% 01 Sep 2021 31 Aug 2022 10-K 20 Nov 2023 2023 FY
2021 $13,419,846 +$10,765,616 +406% 01 Sep 2020 31 Aug 2021 10-K 28 Nov 2022 2022 FY
2020 $2,654,230 -$678,453 -20% 01 Sep 2019 31 Aug 2020 10-K 29 Nov 2021 2021 FY
2019 $3,332,683 +$1,465,459 +78% 01 Sep 2018 31 Aug 2019 10-K 15 Oct 2020 2020 FY
2018 $1,867,224 -$2,128,312 -53% 01 Sep 2017 31 Aug 2018 10-K 14 Nov 2019 2019 FY
2017 $3,995,536 +$3,481,244 +677% 01 Sep 2016 31 Aug 2017 10-K 14 Nov 2018 2018 FY
2016 $514,292 +$141,037 +38% 01 Sep 2015 31 Aug 2016 10-K 14 Nov 2018 2018 FY
2015 $373,255 -$856,336 -70% 01 Sep 2014 31 Aug 2015 10-K 29 Nov 2016 2016 FY
2014 $1,229,591 +$1,594,950 01 Sep 2013 31 Aug 2014 10-K 27 Nov 2015 2015 FY
2013 $365,359 -$652,861 -227% 01 Nov 2012 31 Oct 2013 10-KT 09 Dec 2014 2014 FY
2012 $287,502 -$573,503 -67% 01 Nov 2011 31 Oct 2012 10-K 24 Jan 2014 2013 FY
2011 $861,005 +$512,605 +147% 01 Nov 2010 31 Oct 2011 10-K 29 Jan 2013 2012 FY
2010 $348,400 01 Nov 2009 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.